🇺🇸 Sm-153 in United States

34 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Thrombocytopenia — 6 reports (17.65%)
  2. Metastases To Lung — 4 reports (11.76%)
  3. Abdominal Hernia — 3 reports (8.82%)
  4. Asthenia — 3 reports (8.82%)
  5. Bone Pain — 3 reports (8.82%)
  6. Breast Cancer Metastatic — 3 reports (8.82%)
  7. Cancer Pain — 3 reports (8.82%)
  8. Fatigue — 3 reports (8.82%)
  9. Ileus — 3 reports (8.82%)
  10. Metastases To Central Nervous System — 3 reports (8.82%)

Source database →

Other Oncology approved in United States

Frequently asked questions

Is Sm-153 approved in United States?

Sm-153 does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Sm-153 in United States?

Radiation Therapy Oncology Group is the originator. The local marketing authorisation holder may differ — check the official source linked above.